We identified delayed anemia after ARS treatment using a small subgroup of patients from the current study [16] in whom it was possible to study anemia defined by several criteria (low haptoglobin, elevated lactate dehydrogenase level, decrease inHb, exclusion of sickle cell disease and G6PDH deficiency). The gene discussed is HP; the disease is anemia.